{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:18:39Z","timestamp":1787163519466,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04213-2","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:21:17Z","timestamp":1773012077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lipid accumulation and interstitial lung disease associated with amikacin liposomal inhalation suspension in patients with Mycobacterium avium complex lung disease: a single-center retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Hiroki","family":"Wakabayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Hiruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Kasuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Matsuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"4213_CR1","doi-asserted-by":"publisher","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","volume":"56","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur Respir J. 2020;56:2000535.","journal-title":"Eur Respir J"},{"key":"4213_CR2","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.resinv.2024.09.007","volume":"62","author":"M Ito","year":"2017","unstructured":"Ito M, Furuuchi K, Fujiwara K, Kodama T, Tanaka Y, Yoshiyama T, et al. Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017\u20132021. Respir Investig. 2017;62:1064\u201371.","journal-title":"Respir Investig"},{"key":"4213_CR3","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","volume":"198","author":"DE Griffith","year":"2018","unstructured":"Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, et al. Amikacin liposome Inhalation Suspension for treatment-refractory lung disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med. 2018;198:1559\u201369.","journal-title":"Am J Respir Crit Care Med"},{"key":"4213_CR4","doi-asserted-by":"publisher","first-page":"474122","DOI":"10.1128\/spectrum.04741-22","volume":"11","author":"SM Kim","year":"2023","unstructured":"Kim SM, Chong YP, Lee HJ, Shim TS, Jo K-W. Comparison of treatment outcomes of cavitary mycobacterium avium complex pulmonary disease with streptomycin or amikacin use. Microbiol Spectr. 2023;11:474122.","journal-title":"Microbiol Spectr"},{"key":"4213_CR5","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.2147\/IDR.S373783","volume":"15","author":"A Morita","year":"2022","unstructured":"Morita A, Namkoong H, Yagi K, Asakura T, Hosoya M, Tanaka H, et al. Early-phase adverse effects and management of liposomal amikacin inhalation for refractory mycobacterium avium complex lung disease in real-world settings. Infect Drug Resist. 2022;15:4001\u201311.","journal-title":"Infect Drug Resist"},{"key":"4213_CR6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.chest.2021.03.070","volume":"160","author":"DE Griffith","year":"2021","unstructured":"Griffith DE, Thomson R, Flume PA, Aksamit TR, Field SK, Addrizzo-Harris DJ, et al. Amikacin liposome inhalation suspension for refractory mycobacterium avium complex lung disease. Chest. 2021;160:831\u201342.","journal-title":"Chest"},{"key":"4213_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1513\/AnnalsATS.202008-925OC","volume":"18","author":"KL Winthrop","year":"2021","unstructured":"Winthrop KL, Flume PA, Thomson R, Mange KC, Yuen DW, Ciesielska M, et al. Amikacin liposome inhalation suspension for Mycobacterium avium complex lung disease: A 12-month open-label extension clinical trial. Ann Am Thorac Soc. 2021;18:1147\u201357.","journal-title":"Ann Am Thorac Soc"},{"key":"4213_CR8","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jiac.2023.04.013","volume":"29","author":"D Takao","year":"2023","unstructured":"Takao D, Takeda K, Takazono T, Ozasa M, Ito Y, Ashizawa N, et al. A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension. J Infect Chemother. 2023;29:806\u20138.","journal-title":"J Infect Chemother"},{"key":"4213_CR9","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.2147\/IDR.S427544","volume":"16","author":"K Hashimoto","year":"2023","unstructured":"Hashimoto K, Nii T, Sumitani H, Yokoyama M, Miyamoto S, Mihashi Y, et al. Diagnosis and management of drug-induced interstitial lung disease associated with amikacin liposome inhalation suspension in refractory mycobacterium avium complex pulmonary disease: a case report. Infect Drug Resist. 2023;16:6629\u201334.","journal-title":"Infect Drug Resist"},{"key":"4213_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1513\/AnnalsATS.201303-062OC","volume":"10","author":"G Lee","year":"2013","unstructured":"Lee G, Lee KS, Moon JW, Koh W-J, Jeong B-H, Jeong YJ, et al. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. natural course on serial computed tomographic scans. Ann Am Thorac Soc. 2013;10:299\u2013306.","journal-title":"Ann Am Thorac Soc"},{"key":"4213_CR11","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3389\/fmicb.2018.00915","volume":"9","author":"J Zhang","year":"2018","unstructured":"Zhang J, Leifer F, Rose S, Chun DY, Thaisz J, Herr T, et al. Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages. Front Microbiol. 2018;9:915.","journal-title":"Front Microbiol"},{"key":"4213_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s13318-020-00669-7","volume":"46","author":"CM Rubino","year":"2021","unstructured":"Rubino CM, Onufrak NJ, van Ingen J, Griffith DE, Bhavnani SM, Yuen DW, et al. Population pharmacokinetic evaluation of amikacin liposome inhalation suspension in patients with treatment-refractory nontuberculous mycobacterial lung disease. Eur J Drug Metab Pharmacokinet. 2021;46:277\u201387.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"4213_CR13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s40265-020-01359-z","volume":"80","author":"M Bassetti","year":"2020","unstructured":"Bassetti M, Vena A, Russo A, Peghin M. Inhaled liposomal antimicrobial delivery in lung infections. Drugs. 2020;80:1309\u201318.","journal-title":"Drugs"},{"key":"4213_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/jamp.2008.0693","volume":"22","author":"J Weers","year":"2009","unstructured":"Weers J, Metzheiser B, Taylor G, Warren S, Meers P, Perkins WR. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers. J Aerosol Med Pulm Drug Deliv. 2009;22:131\u20138.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"4213_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2214\/AJR.09.3040","volume":"194","author":"SL Betancourt","year":"2010","unstructured":"Betancourt SL, Martinez-Jimenez S, Rossi SE, Truong MT, Carrillo J, Erasmus JJ. Lipoid pneumonia: spectrum of clinical and radiologic manifestations. Am J Roentgenol. 2010;194:103\u20139.","journal-title":"Am J Roentgenol"},{"key":"4213_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.resinv.2023.07.007","volume":"62","author":"H Tomioka","year":"2024","unstructured":"Tomioka H, Miyazaki Y, Inoue Y, Egashira R, Kawamura T, Sano H, et al. Japanese clinical practice guide 2022 for hypersensitivity pneumonitis. Respir Investig. 2024;62:16\u201343.","journal-title":"Respir Investig"},{"key":"4213_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.rmed.2010.12.001","volume":"105","author":"E Marchiori","year":"2011","unstructured":"Marchiori E, Zanetti G, Mano CM, Hochhegger B. Exogenous lipoid pneumonia. Clinical and radiological manifestations. Respir Med. 2011;105:659\u201366.","journal-title":"Respir Med"},{"key":"4213_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.resinv.2023.12.012","volume":"62","author":"K Morimoto","year":"2024","unstructured":"Morimoto K, Nonaka M, Yamazaki Y, Nakagawa T, Takasaki J, Tsuyuguchi K, et al. Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study. Respir Investig. 2024;62:284\u201390.","journal-title":"Respir Investig"},{"key":"4213_CR19","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.2169\/internalmedicine.8796-21","volume":"61","author":"M Kidogawa","year":"2022","unstructured":"Kidogawa M, Yamasaki K, Nemoto K, Yatera K. Liposomal amikacin inhalation suspension-induced pneumonitis. Intern Med. 2022;61:2547\u20139.","journal-title":"Intern Med"},{"key":"4213_CR20","first-page":"151","volume":"46","author":"N Kohno","year":"1999","unstructured":"Kohno N. Serum marker KL-6\/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest. 1999;46:151\u20138.","journal-title":"J Med Invest"},{"key":"4213_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","volume":"50","author":"N Ishikawa","year":"2012","unstructured":"Ishikawa N, Hattori N, Yokoyama A, Kohno N. Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases. Respir Investig. 2012;50:3\u201313.","journal-title":"Respir Investig"},{"key":"4213_CR22","doi-asserted-by":"publisher","first-page":"1041098","DOI":"10.3389\/fimmu.2022.1041098","volume":"13","author":"J He","year":"2022","unstructured":"He J, Zhang J, Ren X. Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis. Front Immunol. 2022;13:1041098.","journal-title":"Front Immunol"},{"key":"4213_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/thorax.58.10.872","volume":"58","author":"H Ohnishi","year":"2003","unstructured":"Ohnishi H, Circulating. KL-6 levels in patients with drug-induced interstitial lung disease. Thorax. 2003;58:872\u20135.","journal-title":"Thorax"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04213-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04213-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04213-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:29:36Z","timestamp":1776248976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04213-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4213"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04213-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8234124\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Toho University Medical Center Sakura Hospital (Approval number: S23058_S23006). The requirement for informed consent was waived owing to the retrospective nature of the study. Instead, the study details were publicly available on the institutional website, allowing potential participants to opt out. All procedures were performed in accordance with the principles of Declaration of Helsinki and its subsequent amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}